openPR Logo
Press release

Global Noninvasive Prenatal Testing Market to Record a Sluggish CAGR Growth of 10.2% By 2024

09-21-2017 08:45 AM CET | Health & Medicine

Press release from: Persistence Market Research

Global Noninvasive Prenatal Testing Market to Record a Sluggish

Advancing the prenatal care services provided across the globe has become an uphill battle for medical practitioners and drugmakers. Fortunately, this struggle is being eased by active participation of parents from all around the world in protecting the health of their soon-to-be-born babies through prenatal disease detection methods. Noninvasive prenatal testing (NIPT) procedures are, hence, being rapidly adopted, which is prompting healthcare service providers to increase their focus on such prenatal diagnosis & screening services. Persistence Market Research recently published its study on the global market for noninvasive prenatal testing, which projects the market to bring in US$ 1,447.2 Mn revenues by the end of 2024.

View and Download TOC of Non Invasive Prenatal Testing Nipt Market Research Report@ https://www.persistencemarketresearch.com/market-research/non-invasive-prenatal-testing-nipt-market/toc

At present, Persistence Market Research values the global noninvasive prenatal testing market at just over US$ 665 Mn, and expects the market to incur revenue growth at an impressive 10.2% CAGR. According to the report, titled “Noninvasive Prenatal Testing Market: Global Industry Analysis and Forecast, 2016-2024,” the global demand for noninvasive prenatal testing will keep surging on the account of rising innovations in prenatal screening products. Growing presence of ADHD disorders among young adults is also triggering the adoption of noninvasive prenatal testing. Moreover, the demand for noninvasive prenatal tests is expected to grow as a majority of young adults are being introduced to generic medications. Nevertheless, stringent usage regulations and records of drug abuse are expected to curb the growing adoption of noninvasive prenatal testing to some extent.

Some of the prominent companies providing noninvasive prenatal testing in the world are identified as, Ariosa Diagnostics, Inc., BGI Diagnosis Co. Ltd., Berry Genomics Corporation, Illumina, Inc., LifeCodexx AG, Natera, Inc., Sequenom, Inc., Quest Diagnostic Incorporated, and Laboratory Corporation of America Holdings. A majority of these companies are based in the US, which is why North America is projected to procure an average 60% of global NIPT revenues through 2024. The demand for noninvasive prenatal testing will also be more in Asia-Pacific, and the region’s NIPT market is looking at an opportune US$ 18 Mn increment in 2017 over 2016. Europe’s noninvasive prenatal testing revenues, on the other hand, will also grow aggressively – registering a 10% CAGR during the forecast period.

Request and Download Sample Report@ https://www.persistencemarketresearch.com/samples/11218

The report reveals that a considerable share of global NIPT revenues will be derived from higher preference to panel 1 test type. Adoption of panel 1 noninvasive prenatal testing has been projected to rise, bringing in over US$ 850 Mn revenues by the end of 2024. On the hand, global revenues from panel 2 tests are anticipated to soar at a healthy CAGR of 9.7%. Correspondingly, hospitals will remain the largest end-users of noninvasive prenatal testing throughout the forecast period. In the due course of this period, hospitals will not only account for half of global NIPT market value, but will also exhibit revenue growth at highest CAGR of 11.1%.

Global Noninvasive Prenatal Testing Market – Key Trends

Impact of changing lifestyles: Urban livelihood and rising per capita income of individuals has propelled the occurrence of high-risk pregnancies. Unhealthy habits such as smoking, drinking and working around the clock has given rise to complications in maternal and neonatal outcomes.

Advanced maternal age: Occurrence of women in their late 30s giving birth for the first time has increased. To avoid birth defects and consider the advanced age of mother, doctors are also promoting the adoption of noninvasive prenatal screening.

Classification as “LDT”: More healthcare & pharmaceutical companies are entering the global NIPT market as these tests have been tagged as “lab-developed tests” by the FDA.

Buy Full Non Invasive Prenatal Testing Nipt Market Report@ https://www.persistencemarketresearch.com/checkout/11218

About Us 
Persistence Market Research (PMR) is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. PMR boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients’ business needs.
 PMR stands committed to bringing more accuracy and speed to clients’ business decisions. From ready-to-purchase market research reports to customized research solutions, PMR’s engagement models are highly flexible without compromising on its deep-seated research values.
 

Contact
Persistence Market Research Pvt. Ltd
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
media@persistencemarketresearch.com
Web:www.persistencemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Noninvasive Prenatal Testing Market to Record a Sluggish CAGR Growth of 10.2% By 2024 here

News-ID: 730892 • Views:

More Releases from Persistence Market Research

Urolithiasis Management Devices Market Set to Grow and Garner a Share of US$ 2.2 Billion by 2030, Affirms Persistence Market Research
Urolithiasis Management Devices Market Set to Grow and Garner a Share of US$ 2.2 …
Introduction The urolithiasis management devices market has witnessed significant growth in recent years, driven by the increasing prevalence of kidney stones and advancements in minimally invasive treatment options. Urolithiasis, or the formation of stones in the urinary tract, is a growing global health concern linked to changing dietary habits, sedentary lifestyles, and rising incidences of metabolic disorders such as obesity and diabetes. Management devices play a crucial role in the diagnosis,
Endoscopic Closure Systems Market Set to Grow at a 6.7% CAGR, Crossing the US$ 487.8 Million Mark by 2030
Endoscopic Closure Systems Market Set to Grow at a 6.7% CAGR, Crossing the US$ 4 …
Introduction The endoscopic closure systems market has witnessed remarkable growth in recent years due to their critical role in minimally invasive surgical procedures. These systems are primarily used to close gastrointestinal perforations, resection sites, fistulas, and leaks, offering a safe and effective alternative to traditional open surgeries. Known for their efficiency, precision, and patient safety benefits, endoscopic closure systems have become indispensable in gastroenterology, bariatric surgery, oncology, and other medical specialties. Request
At-Home Molecular Testing Market to Reach US$16.3 Bn by 2030, Growing at 6.0% CAGR
At-Home Molecular Testing Market to Reach US$16.3 Bn by 2030, Growing at 6.0% CA …
Introduction The at-home molecular testing market has gained remarkable momentum in recent years, driven by the growing demand for accessible, convenient, and accurate diagnostic solutions. Leveraging advanced molecular technologies such as PCR and isothermal amplification, these tests enable users to detect infectious diseases, genetic conditions, and other health-related biomarkers without visiting traditional healthcare facilities. The increasing focus on patient-centric care, rising awareness about preventive health, and technological advancements in miniaturized diagnostic
Smart Container Market Expected to Surpass US$ 21.5 Bn in 2032 - Persistence Market Research
Smart Container Market Expected to Surpass US$ 21.5 Bn in 2032 - Persistence Mar …
In an era where digital transformation is reshaping every industry, logistics and supply chain management are undergoing one of the most significant shifts with the rise of smart container technology. Traditional shipping containers, once considered merely passive cargo carriers, are now being enhanced with advanced technologies such as IoT (Internet of Things), GPS tracking, temperature and humidity monitoring, and blockchain integration. These innovations are not just optimizing operational efficiency but

All 5 Releases


More Releases for Prenatal

Non-Invasive Prenatal Testing (NIPT) Market Set to Transform Prenatal Care World …
Market Overview The global non-invasive prenatal testing NIPT market reached US$ 6.31 billion in 2023 and increased to US$ 7.35 billion in 2024. It is projected to reach US$ 22.41 billion by 2033, growing at a compound annual growth rate CAGR of 13.2% during the forecast period 2025-2033. The market is driven by the rising prevalence of chromosomal abnormalities, increasing maternal age, and growing demand for safe, non-invasive screening methods. NIPT
Unlocking the Future of Prenatal Care: Insights into the Australia Non-Invasive …
Australia's NIPT market is growing as more parents choose safe, early screening for chromosomal abnormalities. Driven by rising maternal age, advanced sequencing technology, and increasing awareness, NIPT offers high accuracy without invasive procedures. As labs expand test panels and policymakers consider broader reimbursement, NIPT is reshaping prenatal care, making comprehensive and reliable insights accessible to expecting families across Australia. The Australian non-invasive prenatal testing (NIPT) market is undergoing remarkable growth, transforming
Revolutionizing Prenatal Care: Insights into the Growing Non-Invasive Prenatal T …
Mordor Intelligence has published a new report on the Non-invasive Prenatal Testing Market, offering a comprehensive analysis of trends, growth drivers, and future projections. The global non-invasive prenatal testing (NIPT) market is projected to expand significantly, with expectations to grow from USD 3.90 billion in 2025 to USD 7.35 billion by 2030, reflecting a compound annual growth rate (CAGR) of 13.5%. This growth is primarily attributed to
Prenatal Diagnostics Market Companies Overview 2019 - 2027
Global Prenatal Diagnostics Market: Overview Prenatal diagnostics is a procedure for testing the fetus before birth to determine certain hereditary disorders such as Down's syndrome, genetic diseases, chromosome abnormalities, neural tube defects, and other conditions. In case of high risk related to the birth of a child, it can assist by conducting numerous procedures of genetic testing common testing, and screening. Report Overview @ https://www.transparencymarketresearch.com/prenatal-diagnostics-market.html The global prenatal diagnostics market is segmented on
Non-Invasive Prenatal Testing Market : Lucrative Opportunities
Non-Invasive Prenatal Testing Market: Introduction Transparency Market Research has published a new report titled 'Global Non-Invasive Prenatal Testing Market'. According to the report, the global non-invasive prenatal testing market was valued at approximately US$ 1.3 Bn in 2018. The global non-invasive prenatal testing market is expected to expand at a CAGR of 16.4% during the forecast period from 2019 to 2027. Overview Rise in prevalence of chronic conditions, such as cancer and diabetes,
Prenatal Vitamin Supplements Market: Rising Incidence of Prenatal Defects to Fue …
Global Prenatal Vitamin Supplements Market: Overview Prenatal vitamins are the mineral and vitamin supplements used by during their pregnancy for the healthy development of the fetus. Prenatal vitamins are also recommended by doctors before conception and post conception lactation period. These vitamins are like other common man multivitamins but with different concentration of vitamins and some special vitamins required during pregnancy. Most of these vitamins are prescribed as regulated by U.S.